Amrutanjan Health Care reports 35.11% rise in Q3 net profit

13 Mar 2012 Evaluate

Amrutanjan Health Care has reported results for third quarter ended December 31, 2011.

The company has posted a rise of 35.11% in its net profit at Rs 4.31 crore for the quarter ended December 31, 2011 as compared to Rs 3.19 crore for the same quarter in the previous year. Total income has increased by 6.25% at Rs 36.36 crore for the quarter under review as compared to Rs 34.22 crore in the same quarter of 2010.

Amrutanjan Health Care has a wide range of ayurvedic and allopathic products. The company has diversified into various businesses in the health care segment like the Fine Chemical Division and Osmosys Medical Clinic located in Chennai. The company is also planning to consolidate its flagship product category - pain management - to compete with multinational brands such as GSK (Iodex), P&G (Vicks) and Reckitt Benckiser (Moov), more vigorously.

Amrutanjan Healthcar Share Price

655.35 -10.70 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×